Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

XenoPort's CEO Hosts XenoPort XP23829 Clinical Trial Results Call (Transcript)
Seeking Alpha
Saturday, October 6, 2012 - 11:36am
tags:
XenoPort, XP23829, multiple sclerosis, psoriasis
This Big Biotech Has a Big Winner
Motley Fool
Saturday, October 6, 2012 - 11:34am
tags:
Celgene, Abraxane, breast cancer, melanoma
Why XenoPort Shares Popped
Motley Fool
Saturday, October 6, 2012 - 11:33am
tags:
XenoPort
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, October 6, 2012 - 11:32am
tags:
Questcor Pharmaceuticals
Aeterna Zentaris Casts a Lifeline
Motley Fool
Saturday, October 6, 2012 - 11:31am
tags:
Aeterna Zentaris
Why Doesn’t MannKind Have a Partner?
Motley Fool
Saturday, October 6, 2012 - 11:29am
tags:
MannKind
How to Play Vertex Pharmaceuticals at CNBC (video) - Fri 6:25 pm ET
CNBC
Saturday, October 6, 2012 - 11:28am
tags:
Vertex Pharmaceuticals
Cell Therapeutics: Sell Now, Ask Questions Later
Seeking Alpha
Saturday, October 6, 2012 - 11:26am
tags:
Cell Therapeutics
Arena Pharmaceuticals Inc. (ARNA): Today's Featured Drugs Laggard
The Street
Saturday, October 6, 2012 - 11:25am
tags:
Arena Pharmaceuticals
BioMarin Pharmaceuticals Inc (BMRN): Today's Featured Drugs Winner
The Street
Saturday, October 6, 2012 - 11:25am
tags:
Biomarin
Acadia Pharmaceuticals - Breaking Out For A Second Leg Up
Seeking Alpha
Friday, October 5, 2012 - 12:28pm
tags:
Acadia
NICE reverses position on new use for Novartis' Lucentis
Fierce Pharma
Friday, October 5, 2012 - 12:27pm
tags:
NICE, UK, Novartis, Lucentis, diabetic macular edema
Novo to Hire 1,000 People in 2 Years in Emerging Markets
Bloomberg Businessweek
Friday, October 5, 2012 - 12:23pm
tags:
emerging markets, diabetes, Novo Nordisk
Takeda to buy LigoCyte, signs pact with India's Advinus
Pharma Times, UK
Friday, October 5, 2012 - 12:22pm
tags:
Takeda, LigoCyte, India, M&A, Advinus
Insider Sales Case Study: It Is A Deceptive Indicator Of Insider Confidence In A Company
Seeking Alpha
Friday, October 5, 2012 - 12:20pm
tags:
Amarin
Will The Sanofi Pompe Paradigm Play Out With Neuralstem And Lou Gehrig's Disease?
Seeking Alpha
Friday, October 5, 2012 - 12:05pm
tags:
Pompe disease, Sanofi, Neuralstem, Lou Gehrig's disease
FTC Asks Supreme Court To Review Pay To Delay
Pharmalot
Friday, October 5, 2012 - 11:38am
tags:
pay-for-delay, FTC, Supreme Court
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Friday, October 5, 2012 - 11:27am
tags:
Roche, Rituxan, Boehringer Ingelheim, rheumatoid arthritis
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Friday, October 5, 2012 - 11:25am
tags:
Bristol-Myers Squibb, Novo Nordisk, Amylin, diabetes
[video]Is Wall Street Turning on Amarin?
Motley Fool
Friday, October 5, 2012 - 11:22am
tags:
Amarin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.